Alisa Wolberg: Thrilled to Have Been Able to Visit the NIH with ASH and Advocate for Science and the Fight 4 Hematology
Alisa Wolberg, Professor at University of North Carolina at Chapel Hill, reposted from ASH on LinkedIn:
”Thrilled to have been able to visit the NIH with ASH last week and advocate for science and the Fight 4 Hematology”
American Society of Hematology (ASH) shared on LinkedIn:
”Last week, ASH leaders went to The National Institutes of Health (NIH) to advocate for blood research.
Drs. Belinda Avalos, Robert Negrin, Jennifer Brown, and Alisa Wolberg met with NIH and NHLBI leaders to discuss critical priorities in hematology.
Key topics included:
- Protecting federal funding for hematology research
- Supporting early-career investigators through the Fight 4 Hematology campaign
- Updates on NIH peer review and other policy changes that impact research and patient care
These conversations are vital for ensuring hematology research continues to advance, patients benefit from breakthroughs, and the next generation of hematologists is supported.
Learn how you can Fight 4 Hematology.”
Stay updated with Hemostasis Today.
-
Aug 24, 2026, 18:13Chokri Ben Lamine: Ruxolitinib – Comprehensive Clinical Reference
-
Aug 24, 2026, 18:10Yazan Abou-Ismail: ClotCast Episode 8 – What Are Platelets?
-
Aug 24, 2026, 17:11Kristin Neves: Which Hematologic Parameters Guide Your PV Treatment Decisions?
-
Aug 24, 2026, 17:00Should Hormone Therapy Automatically Stop After a Thrombosis? – Thrombosis Canada
-
Aug 24, 2026, 16:52Davide Capodanno: 10 Trials to Watch at the ESC Hot Lines
-
Aug 24, 2026, 16:48Mohd Ashhad: The Science Behind a Safe Transfusion
-
Aug 24, 2026, 16:38PCSK9i Is a Powerful Lipid-Lowering Strategy – But Is It Also Anti-Inflammatory?- JACC Journals
-
Aug 24, 2026, 16:36Alejandro González Veliz։ Does ACC/AHA Lesion Complexity Still Matter?
-
Aug 24, 2026, 16:21Kamlesh Darji: Paraneoplastic Syndromes – Tumor with or without Mediator